Shuei-Liong Lin

Topical antifungal treatment cures exit-site fungal infection.

Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.

Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.

Intrahepatic hemorrhage and subcapsular hematoma developing in acute pancreatitis.

Pentoxifylline inhibits platelet-derived growth factor-stimulated cyclin D1 expression in mesangial cells by blocking Akt membrane translocation.

Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.

Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.

Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.

Pentoxifylline: a potential therapy for chronic kidney disease.

The renoprotective potential of pentoxifylline in chronic kidney disease.

YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.

Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.

Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury.

Bradykinin enhances reactive oxygen species generation, mitochondrial injury, and cell death induced by ATP depletion--a role of the phospholipase C-Ca(2+) pathway.

Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.

Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.

Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney.

Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis.

Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.

Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery.

Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.

Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.

Macrophage Wnt7b is critical for kidney repair and regeneration.

Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.

Patients supported by extracorporeal membrane oxygenation and acute dialysis: acute physiology and chronic health evaluation score in predicting hospital mortality.

Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting.

Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.

Kidney impairment in primary aldosteronism.

Café-au-lait ascites in encapsulating peritoneal sclerosis.

Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury.

Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.

Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment.

Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality.

Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study.

Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.

The role played by perivascular cells in kidney interstitial injury.

Advanced age affects the outcome-predictive power of RIFLE classification in geriatric patients with acute kidney injury.

Clinical outcomes and predictors for ESRD and mortality in primary GN.

U-curve association between timing of renal replacement therapy initiation and in-hospital mortality in postoperative acute kidney injury.

Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.

LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.

Cysteine-rich protein 61 plays a proinflammatory role in obstructive kidney fibrosis.

Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.

More is not better: fluid therapy in critically ill patients with acute kidney injury.

The role of angiopoietin-2 in progressive renal fibrosis.

Decrease in irisin in patients with chronic kidney disease.

TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury.

Reply to comment on: Is the renoprotective effect of erythropoietin in chronic kidney disease a myth?

Hemojuvelin modulates iron stress during acute kidney injury: improved by furin inhibitor.

Association of the variations in the HSD3β gene with primary aldosteronism.

The role of hypoxia-inducible factors in renal fibrosis.

Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.

Stem cells and kidney regeneration.

Microvascular pericytes in healthy and diseased kidneys.

Long-term risk of coronary events after AKI.

Angiopoietin-2-induced arterial stiffness in CKD.

Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury.

Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury.

Enthusiasm for induced pluripotent stem cell-based therapies in kidney regeneration.

Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.

Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.

Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.

Circadian CLOCK Mediates Activation of Transforming Growth Factor-β Signaling and Renal Fibrosis through Cyclooxygenase 2.

DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.

A low-salt diet increases the expression of renal sirtuin 1 through activation of the ghrelin receptor in rats.

Downregulation of angiotensin type 1 receptor and nuclear factor-κB by sirtuin 1 contributes to renoprotection in unilateral ureteral obstruction.

Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury.

Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease.

Renin-Angiotensin System Inhibitor is Associated with Lower Risk of Ensuing Chronic Kidney Disease after Functional Recovery from Acute Kidney Injury.

Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update.

Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.

Physiology and pathophysiology of renal erythropoietin-producing cells.

Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease.

New-Onset Diabetes After Acute Kidney Injury Requiring Dialysis.

Effects of Statin Use in Advanced Chronic Kidney Disease Patients.

Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.

Heart rate variability as a predictor of rapid renal function deterioration in chronic kidney disease patients.

Erythropoietin modulates macrophages but not post-ischemic acute kidney injury in mice.

Short- and long-term outcomes after postsurgical acute kidney injury requiring dialysis.

Emergency department utilization and resuscitation rate among patients receiving maintenance hemodialysis.

Angiopoietin 1 influences ischemic reperfusion renal injury via modulating endothelium survival and regeneration.

Rejuvenation: Turning back the clock of aging kidney.

Inflammatory macrophages switch to CCL17-expressing phenotype and promote peritoneal fibrosis.

Associations between preoperative continuation of renin-angiotensin system inhibitor and cardiac surgery-associated acute kidney injury: a propensity score-matching analysis.

Integrating the Surprise Question, Palliative Care Screening Tool, and Clinical Risk Models to Identify Peritoneal Dialysis Patients With High One-Year Mortality.

Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Hypochlorite-induced porcine model of peritoneal fibrosis through the activation of IL1β-CX3CL1-TGFβ1 signal axis.

Methylation in pericytes after acute injury promotes chronic kidney disease.

Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFβ signaling through TGFBR1 stabilization.

Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis.

Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts.

Outcomes of coronavirus 2019 infection in patients with chronic kidney disease: a systematic review and meta-analysis.

Kidney pericyte hypoxia-inducible factor regulates erythropoiesis but not kidney fibrosis.

The impact of baseline glomerular filtration rate on subsequent changes of glomerular filtration rate in patients with chronic kidney disease.

FGF23 ameliorates ischemia-reperfusion induced acute kidney injury via modulation of endothelial progenitor cells: targeting SDF-1/CXCR4 signaling.

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery.

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA Antibody in IgA Nephropathy Patients.

Characteristics of a Novel K416_F418delinsN Mutation in a Classical Aldosterone-Producing Adenoma.

Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells.

Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling.

Exploring the kidney disease data of Taiwan, a country with the highest incidence and prevalence of treated ESKD worldwide - Hints for public health and policy initiative.

Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis.

Oxidative Stress-Induced Alterations of Cellular Localization and Expression of Aquaporin 1 Lead to Defected Water Transport upon Peritoneal Fibrosis.

Effects of Medium Cut-Off Polyarylethersulfone and Polyvinylpyrrolidone Blend Membrane Dialyzers in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.